Chinese In-Vitro Diagnostics (IVD) Market Worth $17.6B by 2026 - Roche Holds Majority Shares, Followed by Sysmex Corporation and Mindary Medical

News provided by

Mar 13, 2020, 14:15 ET

DUBLIN, March 13, 2020 /PRNewswire/ -- The "China In-Vitro Diagnostics (IVD) Market, Size, Share, Trends, Regulations, Reimbursement & Key Players Analysis - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

China In-Vitro Diagnostics (IVD) market is likely to reach around US$ 17.6 Billion by 2026.

China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. Historically, large multinational companies have dominated IVD market in China; today, domestic companies such as Shanghai Kehua Bio-Engineering (KHB) being one of the largest - are now gaining market share.

China is a large and fast-growing in vitro diagnostics (IVD) market - in fact, only second to the United States in terms of value. China's quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.

China IVD Market Segment Wise Analysis

Immunoassay captures maximum share of the China IVD market.
Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing.
The molecular testing market in China is expected to show double digits growth rate during the forecast period.
China SMBG market is dominated by foreign IVD companies such as Roche.
Microbiology and Hematology segments are competing closely with each other to grab maximum share of the pie.
Point of Care Testing accounts for least share of the China IVD market.

China IVD Market Company Analysis

Roche captures maximum share of the China IVD market.
Sysmex Corporation and Mindary Medical are other top two players in the China IVD market.
Sysmex has built a robust infrastructure in China, working with more than 200 sales distributors to provide products and services throughout the country.
In Abbott's worldwide diagnostics business, sales growth over the last three years reflected the acquisition of Alere in October of 2017.
At present, many local players are present in China IVD market and their combined market share is likely to exceed 60 percent by 2026.

Key Topics Covered

1. Executive Summary

2. China IVD Market and Market Share Analysis (2010 - 2026)
2.1 China IVD Market and Forecast
2.2 China IVD Market Share and Forecast
2.3 China IVD Company Share and Forecast

3. China IVD - Segments Wise Market and Forecast (2010 - 2026)
3.1 China Clinical Chemistry Market and Forecast
3.2 China Immunoassay Market and Forecast
3.3 China Hematology Market and Forecast
3.4 China Coagulation Market and Forecast
3.5 China Microbiology Market and Forecast
3.6 China Molecular Testing Market and Forecast
3.7 China Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
3.8 China Point of Care Testing (POCT) Market and Forecast

4. Development Environment of Chinese IVD Industry
4.1 State Healthcare Reforms
4.2 State Citizen-Benefiting Policies
4.3 Requirements of Hospital Upgrading

5. Profile of In-vitro Diagnostic Reagents Registration Control
5.1 Classification of In-vitro Diagnostic Reagents in China
5.1.1 Class III: Highest Risk
5.1.2 Class II: Medium Risk
5.1.3 Class I: Lower Risk
5.2 Regulatory History in China IVD Market
5.3 Regulatory Status in China IVD Market
5.3.1 Blood Screening Reagents - Drug Administration
5.3.2 Varieties of Blood Screening Reagents
5.3.3 Blood Screening Reagent Test
5.3.4 Nucleic Acid Detection Kits for Blood Screening
5.3.5 Radioactive reagents - Drug Administration
5.3.6 Diagnostic Reagents - Medical Devices Management
5.4 Regulatory Trend in China IVD Market
5.4.1 Blood Screening Reagents Belonging
5.4.2 Quality Improvement
5.4.3 Pre-Evaluation of Registration Standards

6. Registration for In Vitro Diagnostic Reagents in China
6.1 Registration and Filing
6.2 Filing Obligation for Clinical Trials
6.3 Clinical Trial Institutions
6.4 Elimination of IVD Loophole for Research
6.5 Change of Manufacturing Address
6.6 Change of Main Supplier of An Antigen or Antibody
6.7 China In Vitro Diagnostics Registration Update
6.7.1 IVD Product Registration in China
6.7.2 China IVD Type Testing Process
6.7.3 Clinical Trials for IVD Products in China

7. Reimbursement of IVD Products in China

8. China IVD Market - Key Players Sales Analysis (2010 - 2026)
8.1 Roche Diagnostics - China IVD Sales and Forecast
8.2 Abbott Laboratories - China IVD Sales and Forecast
8.3 Sysmex Corporation - China IVD Sales and Forecast
8.4 Mindray Medical International Limited - China IVD Sales and Forecast
8.5 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast
8.6 Others - China IVD Sales and Forecast

9. Profiles of Select Private Clinical Labs and Diagnostic Services Companies
9.1 Dian Diagnostics Group Co. Ltd. (Formerly Zhejiang Di'an Diagnostics Technology Co. Ltd.)
9.1.1 Company Overview
9.1.2 Products and Services Offered by Di'an
9.2 ADICON Clinical Laboratories (Privately held)
9.2.1 Company Overview
9.2.2 Products and Services Offered by ADICON
9.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
9.3.1 Company Overview
9.3.2 Products and Services Offered by Kingmed
9.4 Kindstar Global (Privately held)
9.4.1 Company Overview
9.4.2 Products and Services Offered by Kindstar
9.5 BGI-Shenzhen
9.5.1 Company Overview
9.5.2 BGI's Innovative Approach
9.6 OriGene Technologies
9.6.1 Company Overview
9.6.2 Products and Services Offered by OriGene

10. China IVD Industry Drivers
10.1 Government Efforts to Regulate Laboratory testing
10.2 Increasing Number of Private Hospitals & Independent Testing Laboratories
10.3 Chinese Government Policies Encourage Investment in IVD

11. China IVD Industry Challenge
11.1 Lack of Expertise in Advanced Technology in the Local Companies
11.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
11.3 Reimbursement Rates of Different Products Varies in Different Provinces

List of Figures
Figure 2-1: China - IVD Market (Million US$), 2010 - 2019
Figure 2-2: China - Forecast for IVD Market (Million US$), 2020 - 2026
Figure 2-3: China IVD Market - Company Share (Percent), 2010 - 2019
Figure 2-4: China IVD Market - Forecast for Company Share (Percent), 2020 - 2026
Figure 3-1: China - Clinical Chemistry Market (Million US$), 2010 - 2019
Figure 3-2: China - Forecast for Clinical Chemistry Market (Million US$), 2020 - 2026
Figure 3-3: China - Immunoassay Market (Million US$), 2010 - 2019
Figure 3-4: China - Forecast for Immunoassay Market (Million US$), 2020 - 2026
Figure 3-5: China - Hematology Market (Million US$), 2010 - 2019
Figure 3-6: China - Forecast for Hematology Market (Million US$), 2020 - 2026
Figure 3-7: China - Coagulation Market (Million US$), 2010 - 2019
Figure 3-8: China - Forecast for Coagulation Market (Million US$), 2020 - 2026
Figure 3-9: China - Microbiology Market (Million US$), 2010 - 2019
Figure 3-10: China - Forecast for Microbiology Market (Million US$), 2020 - 2026
Figure 3-11: China - Molecular Testing Market (Million US$), 2010 - 2019
Figure 3-12: China - Forecast for Molecular Testing Market (Million US$), 2020 - 2026
Figure 3-13: China - SMBG Market (Million US$), 2010 - 2019
Figure 3-14: China - Forecast for SMBG Market (Million US$), 2020 - 2026
Figure 3-15: China - POCT Market (Million US$), 2010 - 2019
Figure 3-16: China - Forecast for POCT Market (Million US$), 2020 - 2026
Figure 8-1: Roche Diagnostics - China IVD Revenue (Million US$), 2010 - 2019
Figure 8-2: Roche Diagnostics - Forecast for China IVD Revenue (Million US$), 2020 - 2026
Figure 8-3: Abbott Laboratories - China IVD Revenue (Million US$), 2010 - 2019
Figure 8-4: Abbott Laboratories - Forecast for China IVD Revenue (Million US$), 2020 - 2026
Figure 8-5: Sysmex Corporation - China IVD Revenue (Million US$), 2010 - 2019
Figure 8-6: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2020 - 2026
Figure 8-7: Mindray Medical - China IVD Revenue (Million US$), 2010 - 2019
Figure 8-8: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2020 - 2026
Figure 8-9: Shanghai Kehua - China IVD Revenue (Million US$), 2010 - 2019
Figure 8-10: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2020 - 2026
Figure 8-11: Others - China IVD Revenue (Million US$), 2010 - 2019
Figure 8-12: Others - Forecast for China IVD Revenue (Million US$), 2020 - 2026
Figure 9-1: Kindstar - Collaboration with Hospitals in China (Number), 2006 - 2012
Figure 10-1: China - Healthcare Spending and Forecast (Billion US$), 2011 - 2020

List of Tables
Table 2-1: China - IVD Market Share (Percent), 2010 - 2019
Table 2-2: China - Forecast for IVD Market Share (Percent), 2020 - 2026
Table 10-1: China Food and Drug Administration - Regulation and Impact for Medical Device and IVD Manufacturers Selling in China

For more information about this report visit https://www.researchandmarkets.com/r/o5273c

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets